Regeneron Pharmaceuticals, Inc. (0R2M)
Market Closed
16 Oct, 03:30 PM
$
793. 37
-8.16
-1.0181%
$
- Market Cap
24.52 P/E Ratio
0.22% Div Yield
396 Volume
42.79 Eps
$ 801.53
Previous Close Want to track 0R2M and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Regeneron Pharmaceuticals, Inc. (0R2M) Statistics
Valuation metrics
Market Cap -
Enterprise value 76.44B
Trailing P/E (ttm) 17.83
Forward P/E -
PEG ratio 57.25
Price/Sales (ttm) 4.95
Price/Book (mrq) 2.43
Enterprise Value/Revenue 4.92
Enterprise Value/EBITDA 13.29
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.01K
Average volume (90 days) 698
Price summary
52-Week low 566.5
52-Week high 870
Beta -
50-Day moving average 788.84
200-Day moving average 720.74
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 3.7
Trailing annual dividend yield 0.005%
5-Year annual dividend yield -
Payout ratio 0.09
Dividend Date 31 Aug 2026
Ex-Dividend Date 18 Aug 2026
Last split factor -
Last split Date -
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.28%
Operating margin 0.26%
Operational effectiveness
Return on assets 0.1%
Return on equity 0.14%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 150.24
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 41.86
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 77.32
Total debt (mrq) -
Total Debt/Equity (mrq) 0.06
Current ratio (mrq) 3.34%
Book value per share (mrq) 306.68
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
